Cargando…
Design of a Novel Recombinant Multi-Epitope Vaccine against Triple-Negative Breast Cancer
BACKGROUND: TNBC is determined by the absence of ERBB2, estrogen and progesterone receptors’ expression. Cancer vaccines, as the novel immunotherapy strategies, have emerged as promising tools for treating the advanced stage of TNBC. The aim of this study was to evaluate CEA, MTDH, and MUC-1 protein...
Autores principales: | Dariushnejad, Hassan, Ghorbanzadeh, Vajihe, Akbari, Soheila, Hashemzadeh, Pejman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pasteur Institute of Iran
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987416/ https://www.ncbi.nlm.nih.gov/pubmed/35090304 http://dx.doi.org/10.52547/ibj.26.2.160 |
Ejemplares similares
-
Association of HDAC8 Expression with Pathological Findings in Triple Negative and Non-Triple Negative Breast Cancer: Implications for Diagnosis
por: Menbari, Mohammad-Nazir, et al.
Publicado: (2020) -
Cardioprotective Effect of Crocin Combined with Voluntary Exercise in
Rat: Role of Mir-126 and Mir-210 in Heart Angiogenesis
por: Ghorbanzadeh, Vajihe, et al.
Publicado: (2017) -
In silico Analysis of Pasteurella multocida PlpE Protein Epitopes As Novel Subunit Vaccine Candidates
por: Mostaan, Saied, et al.
Publicado: (2021) -
A Novel Hyperthermostable Recombinant Protein Nanocage
por: Ahmadyousefi, Yaghoub, et al.
Publicado: (2022) -
A photodynamic-mediated glutamine metabolic intervention nanodrug for triple negative breast cancer therapy
por: Yu, Cancan, et al.
Publicado: (2023)